Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Thrombosis Journal

Fig. 1

From: COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

Fig. 1

Initial and long-term anticoagulant therapy in patients with cancerb and a first episode of VTE – data from the RIETE registry [22]. aIncludes unfractionated heparin and thrombolytic agents. bDefined as newly diagnosed cancer, metastatic cancer or cancer undergoing treatment. LMWH, low molecular weight heparin; PE, pulmonary embolism; VKA, vitamin K antagonist; VTE, venous thromboembolism

Back to article page